DEADLINES AND RULES OF SUBMISSION
- Abstracts submitted after 31 OCTOBER 2020 will not be accepted.
- All contributions should be submitted through the online system. Abstracts sent by post or email will not be accepted.
- Presenting authors of abstracts must be registered and paid participants.
- Registration and payment for the conference must take place immediately after the author is informed that the contribution is accepted for presentation. If registration is not made after the author is informed, the abstract will be removed from the system.
- The Programme Committee will endeavour to schedule abstracts according to authors’ preferences but reserves the right to decide on the final form of presentation.
- Abstracts must be original. Formerly published abstracts, either locally or internationally, or which have already been presented at international meetings and/or conferences, cannot be accepted.
- The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.
- As a condition of submission, EIP requires you to agree to surrender any copyright over the abstract as submitted for inclusion in the Abstract Book.
- Abstracts will be published exactly as they are uploaded in the relevant abstract field of the online system and not based on any submitted attachments in doc or PDF format.
- All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. Please use the various tools available online to check your abstract’s grammar and spelling or ask the help of a native English speaker colleague.
- Abstracts stating “data will be discussed in the presentation” will NOT be accepted.
- Abstract submitters will be required to disclose any conflict of interest in the submission form. The presentations are for scientific purposes only and are not to be used for any commercial gain or purpose. To this end, if you have received any form of honoraria or financial support from a commercial company relating to the preparation of your abstract this should be disclosed.
- We ask that brand names of commercial products be avoided unless they are essential both to the content and to the scientific findings of the presentation. Whilst the name of Companies associated with the research should be divulged there should be no use of commercial logos.
ABSTRACT TYPE PREFERENCE
As soon as you enter the system you will be asked to choose the type of your presentation depending on which type describes best the nature of your abstract and whether you wish to present it as an ORAL or POSTER presentation. The form will affect the information you are asked to provide within your abstract.
Type 1 - Oral Presentation: Clinical Audit, Prospective Survey, Clinical Study
Required: (1) Background, (2) Methods, (3) Results, (4) Conclusions. Accepted submissions of this type will be included as a 10 min presentation in one of the moderated Oral Presentations Sessions of the Program (based on selected topic/specialty)
Type 2 - Oral Presentation: Literature Review or Guideline Review
Required: (1) Background and Objective, (2) Methods, (3) Learning Points Discussion. Accepted submissions of this type will be included as a 10 min presentation in one of the moderated Oral Presentations Sessions of the Program (based on selected topic/specialty)
Type 3 - Oral Presentation: Case Report or Case Series
Description of one or more cases providing useful learnings for clinicians. Required: (1) Background, (2) Case Presentation Summary, (3) Learning Points Discussion. Accepted submissions of this type will be included either (1) as a 15 min presentation in a relative track session consisting of a moderator, two invited speakers and 2 case studies authors. (2) as a 10 min presentation in one of the moderated Case Studies Interactive Sessions of the Program (based on selected topic/specialty)
Type 4 - Poster Presentation
Depending on which of the Types 1-3 describes best the nature of your abstract, include the information as required to the relevant type. Accepted submissions of this type will be included (1) as a 3 min presentation in a moderated Poster Theatre Session (2) as a 30 min Poster Viewing in one of Poster Viewings Slots.
ABSTRACT TOPIC SELECTION
Once you select your abstract type, you will choose from one of the below topics to submit your abstract to. The Topic will affect the inclusion of the abstract in the relative specialty conference tracks.
- ADOLESCENT MEDICINE
- ALLERGY, IMMUNOLOGY & RESPIRATORY
- EMERGENCY PEDIATRICS
- GENERAL PEDIATRICS
- HAEMATOLOGY / ONCOLOGY
- HEALTH ECONOMICS & MANAGEMENT
- INFECTIOUS DISEASES
- NUTRITION & DIETS
- PUBLIC HEALTH
- RARE DISEASES
SUBMISSION GUIDELINES AND WHAT TO HAVE ON HAND BEFORE YOU START
Before you submit your abstract, please prepare the following information:
- Presenting author’s contact details should be the same details as the submitting author so that the presenting author receives the correspondence about the abstract. Please use the exact same email address for both your registration to the conference and your abstract submission.
- Author and co-authors’ details. Please ensure you tick the box for the presenting author.
- Selection of Type (abstract type) and preferred Topic & Sub-topic – select the abstract sub-topic as per the list of topics.
- Abstract title – limited to 25 words typed in lowercase letters
- Abstract text word limit to 400 words. The 400 words limit does not include the abstract title and the names and/or affiliations of authors. Details of authors should not be added in the abstract field but in the available fields for authors’ details.
- Tables and Images: You are able to add one table/figure per abstract. Please mark in your abstract’s text where a table, a diagram or a photo should be inserted and upload them as attachments in one of the system’s accepted formats (doc, pdf, jpeg, png). Please note that images/tables may be resized to fit in the final material.
- Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word appears the first time.
- Use generic names of drugs. Express numbers as numerals. The presentation must be balanced and contain no commercial promotional content.
- Submissions may not contain patient names, hospital ID numbers or other identifying information.
- Click on the SUBMIT button at the end of the process in order to submit your abstract.
- You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract. Please contact us if you have not received confirmation that your abstract has been submitted, having first checked your spam folder.
- Please do not submit multiple copies of the same abstract.
- If you have any questions, please do not hesitate to contact us at firstname.lastname@example.org